Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
  1. SC 13G Stake Amended Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 8-K Event Regulation FD disclosure
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 8-K Event Regulation FD disclosure
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G Stake Amended Statement of Ownership
  12. 8-K Event Results of operations
  13. 10-Q Report Quarterly Report
  14. SC 13G Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 16 of 19 · 362 filings